Data / Form D filings / Blue Marlin Therapeutics, Inc.
Blue Marlin Therapeutics, Inc.: Form D filing
Blue Marlin Therapeutics, Inc., a biotechnology company in Charlottesville, VA, filed a Form D with the SEC in 2025. The latest, on October 21, 2025, reports $100,000 sold of an offering with no set size to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 200 GARRETT STREET, SUITE S, Charlottesville, VA, 22902
- Phone
- (434) 980-8104
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2092364
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 21, 2025 | New notice | Indefinite | $100,000 | 2 | Oct 6, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Paul Manning | Executive Officer | |
| Sean Stalfort | Executive Officer |
Other biotechnology companies in Virginia that filed recently
- GENHEALTH, INC. $16.5 million · Sep 29, 2026
- SalivIQ Diagnostics Inc. $1.9 million · Sep 23, 2026
Every Form D from the week of Oct 20, 2025 · All recent filings in Virginia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Blue Marlin Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.